Sectoral Asset Management

Shoulder Innovations is a medical device company that develops inset glenoid fixation technology.

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

Cagent Vascular develops a serration technology for improving the treatment of cardiovascular disease.

Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.

CurvaFix is a medical device company that is developing a novel solution to an unmet need in orthopedic trauma.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases.

Miach Orthopaedics is a medical device company that designs technologies intended to facilitate new tissue growth.